X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. WOCKHARDT LTD. FDC LTD./
WOCKHARDT LTD.
 
P/E (TTM) x 29.1 -15.8 - View Chart
P/BV x 6.1 2.6 234.0% View Chart
Dividend Yield % 0.8 1.3 61.3%  

Financials

 FDC LTD.   WOCKHARDT LTD.
EQUITY SHARE DATA
    FDC LTD.
Mar-14
WOCKHARDT LTD.
Mar-17
FDC LTD./
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1441,129 12.7%   
Low Rs79627 12.6%   
Sales per share (Unadj.) Rs47.6363.1 13.1%  
Earnings per share (Unadj.) Rs7.6-20.4 -37.2%  
Cash flow per share (Unadj.) Rs9.0-7.0 -129.2%  
Dividends per share (Unadj.) Rs2.2510.00 22.5%  
Dividend yield (eoy) %2.01.1 177.6%  
Book value per share (Unadj.) Rs47.5301.8 15.7%  
Shares outstanding (eoy) m177.83110.55 160.9%   
Bonus/Rights/Conversions BBIS-  
Price / Sales ratio x2.32.4 96.7%   
Avg P/E ratio x14.6-42.9 -34.0%  
P/CF ratio (eoy) x12.3-125.9 -9.8%  
Price / Book Value ratio x2.32.9 80.5%  
Dividend payout %29.6-48.9 -60.5%   
Avg Mkt Cap Rs m19,78497,063 20.4%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m1,2219,665 12.6%   
Avg. sales/employee Rs ThNM5,931.8-  
Avg. wages/employee Rs ThNM1,428.1-  
Avg. net profit/employee Rs ThNM-334.0-  
INCOME DATA
Net Sales Rs m8,45940,146 21.1%  
Other income Rs m3941,143 34.4%   
Total revenues Rs m8,85241,289 21.4%   
Gross profit Rs m2,070128 1,617.3%  
Depreciation Rs m2491,489 16.7%   
Interest Rs m312,253 1.4%   
Profit before tax Rs m2,184-2,472 -88.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606-211 -286.9%   
Profit after tax Rs m1,353-2,260 -59.9%  
Gross profit margin %24.50.3 7,676.2%  
Effective tax rate %27.78.5 324.7%   
Net profit margin %16.0-5.6 -284.1%  
BALANCE SHEET DATA
Current assets Rs m4,35546,160 9.4%   
Current liabilities Rs m1,79219,258 9.3%   
Net working cap to sales %30.367.0 45.2%  
Current ratio x2.42.4 101.4%  
Inventory Days Days44101 44.1%  
Debtors Days Days2594 26.2%  
Net fixed assets Rs m3,02540,165 7.5%   
Share capital Rs m179553 32.3%   
"Free" reserves Rs m8,24332,814 25.1%   
Net worth Rs m8,45333,367 25.3%   
Long term debt Rs m1131,903 0.0%   
Total assets Rs m10,55789,687 11.8%  
Interest coverage x71.4-0.1 -73,527.8%   
Debt to equity ratio x01.0 0.1%  
Sales to assets ratio x0.80.4 179.0%   
Return on assets %13.10 -152,715.8%  
Return on equity %16.0-6.8 -236.3%  
Return on capital %23.5-0.3 -7,012.8%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,1469,121 12.6%   
Fx outflow Rs m3552,133 16.7%   
Net fx Rs m7916,988 11.3%   
CASH FLOW
From Operations Rs m1,485-2,695 -55.1%  
From Investments Rs m-620-6,863 9.0%  
From Financial Activity Rs m-75312,545 -6.0%  
Net Cashflow Rs m1133,010 3.7%  

Share Holding

Indian Promoters % 68.9 74.5 92.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 2.3 204.3%  
FIIs % 7.5 7.7 97.4%  
ADR/GDR % 0.0 0.1 -  
Free float % 19.0 15.4 123.4%  
Shareholders   23,730 67,757 35.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  DIVIS LABORATORIES  SUVEN LIFE  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Strong Finish to the Week; Metal & Pharma Stocks Gain(Closing)

Indian share markets finished the trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 23, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS